"The BioTeam recently had the opportunity to perform a set of benchmarks on one of the new quad-chip, dual-core Xeon systems from Intel. Our complete analysis is available online at bioteam.net/intel_benchmarks.
The most interesting thing to me about multicore systems is that they represent a significant push back in the ever-present single system image versus compute farm debate. For the past several years, the most cost-effective way to build a personal compute server at the 8 or 16 CPU level was to build a small cluster out of dual CPU systems. The Intel system that we evaluated contained four physical chips, each of which contained two cores. This made it an 8 CPU system before even counting any virtual CPUs. In terms of performance, administrative overhead, and cost per CPU, a single system is clearly a win over a cluster."
“Bioinformatics will be at the core of biology in the 21st century. In fields ranging from structural biology to genomics to biomedical imaging, ready access to data and analytical tools are fundamentally changing the way investigators in the life sciences conduct research and approach problems. Complex, computationally intensive biological problems are now being addressed and promise to significantly advance our understanding of biology and medicine. No biological discipline will be unaffected by these technological breakthroughs.”BIOINFORMATICS IN THE 21st CENTURY
the panda's thumb
bioinformatics.org / nodalpoint / flags and lollipops / on genetics / a bioinformatics blog / andrew dalke / the struggling grad student / in the pipeline / gene expression / free association / pharyngula / the personal genome / genetics and public health blog / the medical informatics weblog / linuxmednews / nanodot / complexity digest /
nsu / nyt science / bbc scitech / newshub / biology news net /
informatics review / stanford / bmj info in practice / bmj info in practice /
look snazzy and support the site at the same time by buying some snowdeal schwag !
valid xhtml 1.0?
This site designed by
Eric C. Snowdeal III .